Select Ebit vs Selling And Marketing Expenses Analysis
| SEM Stock | USD 27.98 0.39 1.37% |
Select Medical financial indicator trend analysis is much more than just breaking down Select Medical Holdings prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Select Medical Holdings is a good investment. Please check the relationship between Select Medical Ebit and its Selling And Marketing Expenses accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
Ebit vs Selling And Marketing Expenses
Ebit vs Selling And Marketing Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Select Medical Holdings Ebit account and Selling And Marketing Expenses. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Select Medical's Ebit and Selling And Marketing Expenses is -0.62. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Selling And Marketing Expenses in the same time period over historical financial statements of Select Medical Holdings, assuming nothing else is changed. The correlation between historical values of Select Medical's Ebit and Selling And Marketing Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Select Medical Holdings are associated (or correlated) with its Selling And Marketing Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling And Marketing Expenses has no effect on the direction of Ebit i.e., Select Medical's Ebit and Selling And Marketing Expenses go up and down completely randomly.
Correlation Coefficient | -0.62 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Ebit
Selling And Marketing Expenses
Most indicators from Select Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Select Medical Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. At this time, Select Medical's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 2nd of May 2024, Enterprise Value Over EBITDA is likely to grow to 9.89, while Tax Provision is likely to drop about 75.6 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 136.0M | 169.1M | 198.6M | 152.3M | Depreciation And Amortization | 252.4M | 232.2M | 208.7M | 141.4M |
Select Medical fundamental ratios Correlations
Click cells to compare fundamentals
Select Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Select Medical fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 7.3B | 7.7B | 7.4B | 7.7B | 7.7B | 4.9B | |
| Short Long Term Debt Total | 4.5B | 4.5B | 4.7B | 5.1B | 5.0B | 2.9B | |
| Other Current Liab | 535.4M | 623.8M | 708.4M | 687.3M | 735.7M | 772.5M | |
| Total Current Liabilities | 914.3M | 1.4B | 1.3B | 1.2B | 1.2B | 713.0M | |
| Total Stockholder Equity | 929.0M | 1.1B | 1.3B | 1.3B | 1.3B | 788.0M | |
| Property Plant And Equipment Net | 2.0B | 2.0B | 2.0B | 2.2B | 2.2B | 2.3B | |
| Net Debt | 4.2B | 3.9B | 4.6B | 5.0B | 4.9B | 2.8B | |
| Retained Earnings | 279.8M | 553.2M | 593.3M | 581.0M | 751.9M | 789.4M | |
| Accounts Payable | 145.7M | 177.1M | 233.8M | 186.7M | 174.3M | 131.2M | |
| Cash | 335.9M | 577.1M | 74.3M | 97.9M | 84.0M | 110.8M | |
| Non Current Assets Total | 6.1B | 6.1B | 6.2B | 6.4B | 6.4B | 4.0B | |
| Non Currrent Assets Other | 323.9M | 319.2M | 356.7M | 341.7M | 39.6M | 37.7M | |
| Cash And Short Term Investments | 335.9M | 577.1M | 74.3M | 97.9M | 143.0M | 115.1M | |
| Net Receivables | 762.7M | 896.8M | 889.3M | 941.3M | 940.3M | 597.3M | |
| Good Will | 3.4B | 3.4B | 3.4B | 3.5B | 3.5B | 2.5B | |
| Common Stock Shares Outstanding | 130.3M | 129.8M | 130.2M | 124.6M | 123.1M | 134.7M | |
| Liabilities And Stockholders Equity | 7.3B | 7.7B | 7.4B | 7.9B | 7.7B | 4.9B | |
| Non Current Liabilities Total | 5.5B | 5.0B | 4.8B | 5.2B | 4.9B | 3.3B | |
| Other Current Assets | 114.4M | 114.5M | 175.8M | 232.1M | 151.6M | 233.2M | |
| Other Stockholder Equity | 649.1M | 509.1M | 720.2M | 647.8M | 493.4M | 584.2M | |
| Total Liab | 6.4B | 6.4B | 6.0B | 6.3B | 6.1B | 4.1B | |
| Property Plant And Equipment Gross | 2.0B | 2.0B | 2.0B | 1.0B | 3.6B | 3.8B | |
| Total Current Assets | 1.2B | 1.6B | 1.1B | 1.3B | 1.3B | 829.8M | |
| Accumulated Other Comprehensive Income | 0.0 | (2.0M) | 12.3M | 88.6M | 42.9M | 45.1M | |
| Short Term Debt | 233.1M | 233.0M | 246.9M | 281.1M | 346.0M | 363.3M | |
| Intangible Assets | 409.1M | 387.5M | 374.9M | 351.7M | 329.9M | 233.3M | |
| Other Liab | 249.6M | 301.1M | 249.2M | 275.9M | 317.3M | 200.2M | |
| Other Assets | 93.2M | 1.4B | 356.7M | 94.3M | 108.5M | 202.7M | |
| Long Term Debt | 3.4B | 3.4B | 3.6B | 3.8B | 3.6B | 2.6B | |
| Property Plant Equipment | 998.4M | 943.4M | 961.5M | 2.2B | 2.5B | 2.6B | |
| Net Tangible Assets | (2.1B) | (2.3B) | (2.7B) | 804.3M | 723.9M | 760.1M | |
| Noncontrolling Interest In Consolidated Entity | 158.1M | 192.5M | 215.9M | 234.6M | 269.8M | 283.3M | |
| Retained Earnings Total Equity | 279.8M | 553.2M | 593.3M | 581.0M | 668.2M | 401.2M | |
| Long Term Debt Total | 3.4B | 3.4B | 3.6B | 3.8B | 4.4B | 2.9B | |
| Capital Surpluse | 491.0M | 509.1M | 504.3M | 452.2M | 520.0M | 521.3M |
Currently Active Assets on Macroaxis
When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Select Medical Holdings information on this page should be used as a complementary analysis to other Select Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Select Stock analysis
When running Select Medical's price analysis, check to measure Select Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Select Medical is operating at the current time. Most of Select Medical's value examination focuses on studying past and present price action to predict the probability of Select Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Select Medical's price. Additionally, you may evaluate how the addition of Select Medical to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Select Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.668 | Dividend Share 0.5 | Earnings Share 1.91 | Revenue Per Share 54.133 | Quarterly Revenue Growth 0.049 |
The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.